Bladder cancer: Etiology and prevention;Ätiologie und prävention des harnblasenkarzinoms: Teil 1 der serie zum harnblasenkarzinom

Deutsches Arzteblatt

Volumn 104, Issue 11, 2007, Pages 719-723

  Golka, Klaus ^a   Goebell, Peter Jürgen ^b   Rettenmeier, Albert Wolfgang ^b  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^b IV Medizinische Klinik   (Germany)

Author keywords

Bladder cancer; Cancer prophylaxis; Occupational disease; Prevention; Smoking

Indexed keywords

AROMATIC AMINE; AZO DYE;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CIGARETTE SMOKING; HIGH RISK POPULATION; HUMAN; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 34247634527     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. International Agency for Research on Cancer (IARC), ed.: Tobacco smoke and involuntary smoking. Lyon: World Health Organization (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2004; 83.
2. Brennan P, Bogillot O, Cordier S et at: Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000; 86: 289-94.
3. Brennan P, Bogillot O, Greiser E et al.: The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 2001; 12: 411-7.
4. Vineis R Marinelli D, Autrup H et at: Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: A pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 2001; 10: 1249-52.
5. Doll R, Peto R: The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-308.
6. Colditz G, DeJong W, Hunter D, Trichopoulos D, Willet HW, eds.: Harvard report on cancer prevention Vol 1: Causes of human cancer. Cancer Causes Control 1996; 7(Suppl.): S3-59.
7. Hauptverband der gewerblichen Berufsgenossenschaften (HVBG), Hrsg.: Beruflich verursachte Krebserkrankungen. Eine Darsteilung der im Zeitraum 1978 bis 2003 anerkannten Berufskrankheiten. 8, überarbeitete und ergänzte Auflage Sankt Augustin: Hrsg. 2005. www.hvbg.de/d/pages/service/publik/pdf_bild/ krebs.pdf
8. Sorahan T, Hamilton L, Jackson JR: A further cohod study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-beta-naphthylamine and o-toluidine. Occup Environ Med 2000; 57: 106-15.
9. Strait K, Weiland SK, Werner B, Chambless L, Mundt KA, Keil U: Workplace risk factors for cancer in the German rubber industry: Part 2: Mortality from non-respiratory cancers. Occup Environ Med 1998; 55: 325-32.
10. Golka K, Prior V, Blaszkewicz M et al.: Occupational history aspects and genetic N-acetyltransferase (NAT2) polymorphism in urothelial cancer patients in Leverkusen, Germany. Scand J Work Environ Health 1996; 22: 332-8.
11. Golka K, Kopps S, Myslak ZW: Carcinogenicity of azo colorants: influence of solubility and bioavailability. Toxicol Lett 2004; 151: 203-10.
12. Myslak ZW, Bolt HM, Brockmann W: Tumors of the urinary bladder in painters: a case-control study. Am J Ind Med 1991; 19: 705-13.
13. Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK: Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001; 91: 575-9.
14. Gago-Dominguez M, Bell DA, Watson MA et al.: Permanent hair dyes and bladder cancer: risk modification by cytochrome P450 1A2 and N-acetyltransferases 1 and 2. Carcinogenesis 2003; 24: 483-9.
15. Manz A: Harnwegskarzinome bei Beschäftigten der Gasindustrie. Münch Med Wschr 1976; 118: 65-8.
16. Rönneberg A, Langmark F: Epidemiologic evidence of cancer in aluminium reduction plant workers. Am J Ind Med 1992; 22: 573-90.
17. Hammond EC, Selikoff IJ, Lawther PL, Seidman H: Inhalation of benzpyrene and cancer in man. Ann NY Acad Sci 1976; 271: 116-24.
18. Letzel S, Letzel H, Blümner E, Hendrichs A, Sommerburg C: Haut-, Bronchial-, Kehlkopf- und Harnwegskarzinommorbidität bei Patienten mit berufsbedingter Teerhaut. Sankt Augustin: HVBG 1992.
19. Golka K, Bandel T, Reckwitz T et al.: Berufliche Risiken des Hamblasenkarzinoms. Eine Fallkontrollstudie. Urologe [A] 1999; 38: 358-63.
20. Schifflers E, Jamart J, Renard V: Tobacco and occupation as risk factors in bladder cancer: a case-control study in southern Belgium. Int J Cancer 1987; 39: 287-92.
21. Goebell PJ, Villanueva CM, Rettenmeier AW, Rübben H, Kogevinas M: Environmental exposure, chlorinated drinking water, and bladder cancer. World J Urol 2004; 21: 424-32.
22. Chen YC, Su HJ, Guo YL et al.: Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 2003; 14: 303-10.
23. Travis LB, Curtis RE, Glimelius B et al.: Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995; 87: 524-30.
24. Boice Jr JD, Day NE, Andersen A et al.: Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985; 74: 955-75.
25. Dolin PJ, Darby SC, Beral V: Paraplegia and squamous cell carcinoma of the bladder in young women: findings from a case-control study. Br J Cancer. 1994; 70: 167-8.